Scarica l'app Stockscreener
0.583
6.52%
0.0357
Dopo l'orario di chiusura:
.59
0.007
+1.20%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTSO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.5473
Aprire:
$0.59
Volume 24 ore:
253.01K
Relative Volume:
2.75
Capitalizzazione di mercato:
$36.55M
Reddito:
$37.06M
Utile/perdita netta:
$-8.20M
Rapporto P/E:
-4.3736
EPS:
-0.1333
Flusso di cassa netto:
$-12.87M
1 W Prestazione:
-2.85%
1M Prestazione:
-22.16%
6M Prestazione:
-40.81%
1 anno Prestazione:
-41.70%
Intervallo 1D:
$0.5314
$0.5926
Intervallo di 1 settimana:
$0.5263
$0.62
Portata 52W:
$0.4992
$1.39
Cytosorbents Corp Stock (CTSO) Company Profile
Nome
Cytosorbents Corp
Settore
Industria
Telefono
973-329-8885
Indirizzo
305 COLLEGE ROAD EAST, PRINCETON, NJ
Compare CTSO vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
0.583 | 36.55M | 37.06M | -8.20M | -12.87M | -0.1333 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-09-07 | Iniziato | B. Riley Securities | Buy |
| 2021-10-14 | Ripresa | B. Riley Securities | Buy |
| 2020-09-17 | Iniziato | Jefferies | Buy |
| 2020-09-01 | Iniziato | SVB Leerink | Outperform |
| 2017-08-08 | Reiterato | Maxim Group | Buy |
| 2016-10-26 | Iniziato | Aegis Capital | Buy |
| 2016-05-24 | Iniziato | Maxim Group | Buy |
| 2015-10-29 | Aggiornamento | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | Reiterato | MLV & Co | Buy |
| 2015-04-01 | Reiterato | MLV & Co | Buy |
| 2015-03-05 | Iniziato | MLV & Co | Buy |
| 2015-02-25 | Iniziato | WBB Securities | Speculative Buy |
| 2015-01-27 | Reiterato | H.C. Wainwright | Buy |
Mostra tutto
Cytosorbents Corp Borsa (CTSO) Ultime notizie
Cytosorbents granted 180-day extension by Nasdaq to meet minimum bid price - Investing.com South Africa
CytoSorbents Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq gives CytoSorbents (NASDAQ: CTSO) more time on $1 bid rule - Stock Titan
CytoSorbents Corp (HQE1.MU) stock price, news, quote and history - Yahoo Finance UK
CytoSorbents Corporation 2025 Annual Report: Blood Purification Technologies, Clinical Trials, and Regulatory Insights - minichart.com.sg
Cytosorbents 10-K: Revenue $37.1M, EPS not disclosed - TradingView
CytoSorbents (NASDAQ: CTSO) outlines global blood purification push and FDA path - Stock Titan
Cytosorbents’ Earnings Call Balances Progress and Risk - The Globe and Mail
Cytosorbents Corporation (NASDAQ:CTSO) Q4 2025 Earnings Call Transcript - Insider Monkey
Cytosorbents (CTSO) Q4 2025 Earnings Transcript - AOL.com
CytoSorbents 2025 Financials: Q4 & Annual Revenue and Loss ReportNews and Statistics - IndexBox
Cytosorbents Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
H.C. Wainwright reiterates CytoSorbents stock rating at Neutral By Investing.com - Investing.com Canada
H.C. Wainwright reiterates CytoSorbents stock rating at Neutral - Investing.com
CytoSorbents Reports 2025 Financial Results: Revenue Growth, Clinical Advances, and Path to Cash Flow Breakeven in 2026 - minichart.com.sg
CytoSorbents (CTSO) Reports Slight Revenue Increase and Strategi - GuruFocus
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - Finviz
CytoSorbents Corp (CTSO) Q4 2025 Earnings Call Highlights: Navigating Growth and Regulatory ... By GuruFocus - Investing.com Canada
CytoSorbents Corp (CTSO) Q4 2025 Earnings Call Highlights: Navigating Growth and Regulatory Challenges - GuruFocus
Earnings call transcript: CytoSorbents reports Q4 2025 earnings miss, shares dip - Investing.com Australia
Cytosorbents Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Cytosorbents (CTSO) Reports Record Sales Growth in 2025 - GuruFocus
CytoSorbents Corp (NASDAQ:CTSO) Reports Q4 2025 Earnings Miss, Stock Declines - ChartMill
CytoSorbents: Q4 Earnings Snapshot - Barchart.com
CYTOSORBENTS ($CTSO) Releases Q4 2025 Earnings - Quiver Quantitative
Cytosorbents Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
Cytosorbents (CTSO) Expected to Announce Earnings on Monday - Defense World
If You Invested $1,000 in Cytosorbents Corp (CTSO) - Stock Titan
CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 - Fidelity
Aug Drivers: How does Cytosorbents Corporation score in quality rankingsMarket Growth Summary & Safe Capital Growth Plans - baoquankhu1.vn
CytoSorbents Corp Stock (ISIN: US23283M1018) Faces Analyst Hold Amid Massive Upside Potential - AD HOC NEWS
Cytosorbents CorporationCommon Stock (Nasdaq:CTSO) Stock Quote - The Chronicle-Journal
CytoSorbents (CTSO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
CTSO PE Ratio & Valuation, Is CTSO Overvalued - Intellectia AI
Aug Fed Impact: Will Cytosorbents Corporation benefit from government policy2025 Fundamental Recap & Reliable Breakout Stock Forecasts - baoquankhu1.vn
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - BioSpace
CTSO SEC FilingsCytosorbents Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Latest CTSO NewsCytoSorbents Announces the REFRESH 2-AKI Tr... - Stock Titan
CTSO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CTSO.O PE Ratio & Valuation, Is CTSO.O Overvalued - Intellectia AI
Travel Stocks: What makes Cytosorbents Corporation stock attractive today2025 Top Decliners & Real-Time Price Movement Reports - baoquankhu1.vn
Head to Head: Cytosorbents vs. Futureworld - National Today
Investment Report: Can Brookfield Business Partners LP Limited Partnership keep up with sector leadersInsider Selling & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Analysts Expect Breakeven For Cytosorbents Corporation (NASDAQ:CTSO) Before Long - Yahoo Finance
Avenir reports 8.3% Cytosorbents (CTSO) ownership stake in 13G/A - Stock Titan
Aug Final Week: Is WaFd Inc stock undervalued right nowDay Trade & Reliable Price Breakout Alerts - baoquankhu1.vn
Aug PreEarnings: What makes Cytosorbents Corporation stock attractive today2025 Trade Ideas & Smart Allocation Stock Tips - baoquankhu1.vn
Rally Mode: Is Cytosorbents Corporation stock forming a cup and handleJuly 2025 Closing Moves & Trade Opportunity Analysis - baoquankhu1.vn
Trading Recap: What is CFBKs 5 year growth outlookQuarterly Risk Review & Safe Entry Point Identification - baoquankhu1.vn
Insider Buy: What is the earnings history of Cytosorbents CorporationMarket Sentiment Report & Weekly Chart Analysis and Guides - baoquankhu1.vn
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update - BioSpace
Cytosorbents Corp Azioni (CTSO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):